Abstract
Δ9-Tetrahydrocannabinol (THC), the psychoactive ingredient of marijuana, has useful medicinal properties but also undesirable side effects. The brain receptor for THC, CB1, is also activated by the endogenous cannabinoids anandamide and 2-arachidonylglycerol (2-AG). Augmentation of endocannabinoid signaling by blockade of their metabolism may offer a more selective pharmacological approach compared with CB1 agonists. Consistent with this premise, inhibitors of the anandamide-degrading enzyme fatty acid amide hydrolase (FAAH) produce analgesic and anxiolytic effects without cognitive defects. In contrast, we show that dual blockade of the endocannabinoid-degrading enzymes monoacylglycerol lipase (MAGL) and FAAH by selected organophosphorus agents leads to greater than ten-fold elevations in brain levels of both 2-AG and anandamide and to robust CB1-dependent behavioral effects that mirror those observed with CB1 agonists. Arachidonic acid levels are decreased by the organophosphorus agents in amounts equivalent to elevations in 2-AG, which indicates that endocannabinoid and eicosanoid signaling pathways may be coordinately regulated in the brain.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sugiura, T. et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89–97 (1995).
Devane, W.A. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946–1949 (1992).
Agarwal, N. et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat. Neurosci. 10, 870–879 (2007).
Hohmann, A.G. et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 435, 1108–1112 (2005).
Centonze, D., Finazzi-Agrò, A., Bernardi, G. & Maccarrone, M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol. Sci. 28, 180–187 (2007).
Monory, K. et al. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455–466 (2006).
Matias, I., Bisogno, T. & Di Marzo, V. Endogenous cannabinoid in the brain and peripheral tissues: regulation of their levels and control of food intake. Int. J. Obes. (Lond) 30 (suppl. 1) 7–12 (2006).
Di Marzo, V. & Petrosino, S. Endocannabinoids and the regulation of their levels in health and disease. Curr. Opin. Lipidol. 18, 129–140 (2007).
Di Marzo, V., Disogno, T. & De Petrocellis, L. Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem. Biol. 14, 741–756 (2007).
Cravatt, B.F. et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 98, 9371–9376 (2001).
Dinh, T.P. et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 99, 10819–10824 (2002).
Dinh, T.P., Kathuria, S. & Piomelli, D. RNA interference suggests a primary role for monoacylglycerol lipase in degradation of the endocannabinoid 2-arachidonoylglycerol. Mol. Pharmacol. 66, 1260–1264 (2004).
Blankman, J.L., Simon, G.M. & Cravatt, B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347–1356 (2007).
Pertwee, R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarian. Br. J. Pharmacol. 153, 199–215 (2008).
Saario, S.M. & Laitinen, J.T. Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. Basic Clin. Pharmacol. Toxicol. 101, 287–293 (2007).
McKinney, M.K. & Cravatt, B.F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411–432 (2005).
Casida, J.E. & Quistad, G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 17, 983–998 (2004).
Martin, B.R. et al. Cannabinoid properties of methylfluorophosphonate analogs. J. Pharmacol. Exp. Ther. 294, 1209–1218 (2000).
Quistad, G.B., Klintenberg, R., Caboni, P., Liang, S.N. & Casida, J.E. Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol. Appl. Pharmacol. 211, 78–83 (2006).
Pertwee, R.G. Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 76, 1307–1324 (2005).
Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. & Bonner, T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96, 5780–5785 (1999).
Gupta, R.C. Toxicology of Organophosphate & Carbamate Compounds Ch. 9 (Elsevier Academic, San Diego, 2006).
Liu, Y., Patricelli, M.P. & Cravatt, B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96, 14694–14699 (1999).
Evans, M.J. & Cravatt, B.F. Mechanism-based profiling of enzyme families. Chem. Rev. 106, 3279–3301 (2006).
Barglow, K.T. & Cravatt, B.F. Activity-based protein profiling for the functional annotation of enzymes. Nat. Methods 4, 822–827 (2007).
Leung, D., Hardouin, C., Boger, D.L. & Cravatt, B.F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21, 687–691 (2003).
Li, W., Blankman, J.L. & Cravatt, B.F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. J. Am. Chem. Soc. 129, 9594–9595 (2007).
Winrow, C.J. et al. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 33, 477–485 (2003).
Jessani, N. et al. A streamlined platform for high-content functional proteomics of primary human specimens. Nat. Methods 2, 691–697 (2005).
Siegel, G.J. Basic Neurochemistry 7th edn, Ch. 33 (Elsevier Academic, Burlington, Massachusetts, USA, 2006).
Rosenberger, T.A., Villacreses, N.E., Contreras, M.A., Bonventre, J.V. & Rapoport, S.I. Brain lipid metabolism in the cPLA2 knockout mouse. J. Lipid Res. 44, 109–117 (2003).
Nomura, D.K. et al. A brain detoxifying enzyme for organophosphorus nerve poisons. Proc. Natl. Acad. Sci. USA 102, 6195–6200 (2005).
Chiang, K.P., Niessen, S., Saghatelian, A. & Cravatt, B.F. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem. Biol. 13, 1041–1050 (2006).
Nomura, D.K. et al. Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. Toxicol. Appl. Pharmacol. 228, 42–48 (2008).
Quistad, G.B., Barlow, C., Winrow, C.J., Sparks, S.E. & Casida, J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl. Acad. Sci. USA 100, 7983–7987 (2003).
Wu, S.-Y. & Casida, J.E. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Toxicol. Appl. Pharmacol. 139, 195–202 (1996).
Gross, N.J. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu. Rev. Physiol. 57, 135–150 (1995).
Perrier, J., Durand, A., Giardina, T. & Puigserver, A. Catabolism of intracellular N-terminal acetylated proteins: involvement of acylpeptide hydrolase and acylase. Biochimie 87, 673–685 (2005).
Haemmerle, G. et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. J. Biol. Chem. 277, 4806–4815 (2002).
Osuga, J. et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy but not in obesity. Proc. Natl. Acad. Sci. USA 97, 787–792 (2000).
Savinainen, J.R., Saario, S.M., Niemi, R., Järvinen, T. & Laitinen, J.T. An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors. Br. J. Pharmacol. 140, 1451–1459 (2003).
Segall, Y., Quistad, G.B. & Casida, J.E. Cannabinoid CB1 receptor chemical affinity probes: methods suitable for preparation of isopropyl [11,12-3H]dodecylfluorophosphonate and [11,12-3H]dodecanesulfonyl fluoride. Synth. Commun. 33, 2151–2159 (2003).
Wu, S.-Y. & Casida, J.E. Ethyl octylphosphonofluoridate and analogs: optimized inhibitors of neuropathy target esterase. Chem. Res. Toxicol. 8, 1070–1075 (1995).
Quistad, G.B., Sparks, S.E. & Casida, J.E. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. Toxicol. Appl. Pharmacol. 173, 48–55 (2001).
Acknowledgements
This work was supported by grants ES008762 (J.E.C.) and CA087660 (B.F.C.) from the US National Institutes of Health and by the University of California Toxic Substances Research and Teaching Program (D.K.N.). We thank our University of California, Berkeley colleagues H.-S. Sul and M. Ahmadian for equipment in hypothermia experiments, R. Nichiporuk and U. Andersen for advice in the mass spectrometry studies and K. Durkin and T. Clark for graphical assistance. J. Burston, J. Wiley and A. Lichtman of Virginia Commonwealth University provided the data on guanosine triphosphate binding. We thank C. Lupica and A. Zimmer (US National Institutes of Health) for the Cnr1−/− mice.
Author information
Authors and Affiliations
Contributions
D.K.N. designed and performed experiments and wrote the paper. J.L.B., G.M.S., K.F., R.S.I. and A.M.W. performed experiments. B.F.C. and J.E.C. designed experiments and wrote the paper.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–3 and Supplementary Tables 1 and 2 (PDF 309 kb)
Rights and permissions
About this article
Cite this article
Nomura, D., Blankman, J., Simon, G. et al. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol 4, 373–378 (2008). https://doi.org/10.1038/nchembio.86
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.86
This article is cited by
-
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids
Journal of Neuroinflammation (2020)
-
Functional annotation of serine hydrolases in the asexual erythrocytic stage of Plasmodium falciparum
Scientific Reports (2019)
-
Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
Inflammation and Regeneration (2018)
-
WWL70 attenuates PGE2 production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism
Journal of Neuroinflammation (2017)
-
Kinetic interactions of a neuropathy potentiator (phenylmethylsulfonyl fluoride) with the neuropathy target esterase and other membrane bound esterases
Archives of Toxicology (2014)